研究者情報
検索ページ

（最終更新日：2026-05-25 10:08:25）   ウメモト　クミコ   UMEMOTO KUMIKO   梅本久美子    所属   医学部医学科 臨床腫瘍学    職種   講師

■ 学術雑誌 1. 原著　 Diagnostic performance of droplet digital PCR for KRAS mutation analysis in pancreatic cancer cytology specimens 2026/05 2. 原著　 Efficacy and safety of FOLFOX for Japanese patients with advanced biliary tract cancer as second-line or later chemotherapy (JON2107-B study) 2025/12 3. 原著　 Outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1 treatment: A propensity score-matched analysis 2025/12 4. 原著　 Combination chemotherapy for older patients with unresectable biliary tract cancer: a prospective observational study using propensity-score matched analysis (JON2104-B) 2025/09 5. 原著　 Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001) 2025/09 6. 原著　 Efficacy of liposomal irinotecan + 5-FU/LV vs. S-1 in gemcitabine-refractory metastatic pancreatic cancer: a real-world study using inverse probability of treatment weighting 2025/03 7. 原著　 Efficacy of Zenocutuzumab in NRG1 Fusion-Positive Cancer 2025/02 8. 総説・解説　 進行もしくは再発膵癌におけるUGT1A1遺伝子多型とイリノテカンとの関連性 2024/11 9. 原著　 Clinical utility of BRCA and ATM mutation status in circulating tumour DNA for treatment selection in advanced pancreatic cancer 2024/10 10. 原著　 Genomic Profiling of Small Intestine Cancers From a Real-World Data Set Identifies Subgroups With Actionable Alterations. 2024/08 11. 原著　 Quality-of-life survey of pancreatic cancer patients: a comparison between general public and physicians 2024/07 12. 原著　 Current status of the cost burden of first-line systemic treatment for patients with advanced hepatocellular carcinoma in Japan, 2021–22 2024/06 13. 総説・解説　 Microsatellite instability: A 2024 update. 2024/06 14. 原著　 The molecular landscape of gastric cancers for novel targeted therapies from real-world genomic profiling. 2024/05 15. 原著　 Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer 2024/02 16. 原著　 The Phase I/II eNRGy Trial: Zenocutuzumab in Patients with Cancers Harboring NRG1 Gene Fusions 2024/02 17. 原著　 Identification of an optimal mutant allele frequency to detect activating KRAS, NRAS, and BRAF mutations in a commercial cell-free DNA next-generation sequencing assay in colorectal and pancreatic adenocarcinomas 2023/10 18. 総説・解説　 Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment 2023/08 19. 原著　 Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment 2023/06 20. 原著　 Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer. 2023/05 21. 原著　 Clinical significance of circulating-tumour DNA analysis by metastatic sites in pancreatic cancer 2023/04 22. 原著　 Efficacy of chemotherapy for patients with metastatic or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis 2022/12 23. 原著　 Nivolumab for treating patients with occupational cholangiocarcinoma 2022/11 24. 原著　 Comparing the Efficacy and Safety of Gemcitabine plus Nab-Paclitaxel versus Gemcitabine Alone in Older Adults with Unresectable Pancreatic Cancer 2022/10 25. 原著　 The molecular landscape of pancreatobiliary cancers for novel targeted therapies from real-world genomic profiling. 2022/05 26. 原著　 Clinical Utility of Genomic Profiling Tests in Patients with Advanced Gastrointestinal Cancers 2022/03 27. 原著　 Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment 2022/03 28. 総説・解説　 The potential targeted drugs for fusion genes including NRG1 in pancreatic cancer 2021/10 29. 原著　 FOLFIRINOX in advanced pancreatic cancer patients with the double-variant type of UGT1A1 *28 and *6 polymorphism: a multicenter, retrospective study 2021/03 30. 原著　 Impact of Body Weight Loss on Survival in Patients with Advanced Gastric Cancer Receiving Second-Line Treatment 2021/03 31. 原著　 Tolerability of Nab-Paclitaxel Plus Gemcitabine as Adjuvant Setting in Japanese Patients With Resected Pancreatic Cancer 2021/01 32. 症例報告　 Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report 2020/11 33. 原著　 The potential application of PD-1 blockade therapy for early-stage biliary tract cancer 2020/04 5件表示 全件表示(33件)

■ 著書 1. 部分執筆　 肝細胞がん「新臨床腫瘍学改訂第7版」 2024/02 2. 部分執筆　 若年膵癌とKRAS変異「胆と膵」 2023/07

■ 学会発表 1. がん領域における遠隔医療を活用した臨床試験リモート・プレスクリーニングの実現可能性と臨床的有用性 （口頭発表） 2026/03/28 2. Clinical Utility of Liquid CGP in Colorectal Cancer: Real-World Single-Institution Experience （ポスター） 2026/03/27 3. ゲノムプロファイリングに基づいたダブラフェニブ+トラメチニブ療法が奏効した膵腺房細胞癌の一例 （ポスター） 2026/03/27 4. 胆膵系悪性腫瘍における組織CGP不適格例に対する対応とリキッドCGPの有用性 （口頭発表，一般） 2026/03/27 5. 切除不能膵癌における予測バイオマーカーとしての個別化ctDNA動態の臨床的有用性:ARTEMIS-PC研究 （口頭発表） 2026/03/26 6. 外来化学療法における事前採血が待機時間に与える影響に関する前向き観察研究 （口頭発表） 2026/03/26 7. 集学的治療により長期無再発生存を得られた縦隔原発混合性胚細胞腫瘍の1例 （ポスター） 2026/03/26 8. 切除不能胃脂肪肉腫に対し化学療法後に根治切除可能となった1例 （ポスター，一般） 2026/03/06 9. A phase Ⅱstudy of re-introduction of gemcitabine pluscisplatin in combination with durvalumab after durvalumab maintenance therapy in patients with unresectable or recurrent biliary tract cancer (PRIDE study). （ポスター） 2026/01/10 10. ”難しいから面白い” を伝えるために （口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2025/07/26 11. Mutational Profiles of Pancreatic Cancer Patients from Eastern Asia Using Somatic Exome Sequencing （ポスター） 2025/04 12. 進行性大腸癌に対するRAS/BRAF変異別のCGP検査の臨床的意義 （ポスター） 2025/03/08 13. 膵癌の細胞診検体を用いたデジタルPCRによるKRAS変異同定の臨床的妥当性の検討 （口頭発表） 2025/03/06 14. 膵癌患者における細胞診検体の ddPCR 解析を用いた KRAS 変異測定 （口頭発表，一般） 2024/10 15. 当院における”胆道・膵臓病センター”の設置から現在までのと今後の課題 （口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2024/07/25 16. 切除不能進行再発大腸癌（mCRC）における血漿を用いた包括的ゲノムプロファイリング（CGP）のRAS/BRAF変異別の意義 （口頭発表） 2024/07/12 17. 通過障害を合併したStage IVB食道癌に対する治療選択と臨床転帰の評価 （ポスター） 2024/07/04 18. Characterization of patients with advanced biliary tract cancer by KRAS alteration subtypes （口頭発表） 2024/02/24 19. Clinical significance of plasma-based comprehensive genomic profiling in metastatic colorectal cancer by RAS/BRAF status （口頭発表，一般） 2024/02/24 20. 患者と主治医の抗がん剤による副作用のつらさと休薬希望度の差に関する意識調査 （口頭発表） 2024/02/24 21. A feasibility study to evaluate clinical utility of stress data collection in cancer patients treated with chemotherapy （口頭発表） 2024/02/22 22. Clinical course of skin rashes caused by neoadju-vant gemcitabine plus S-1 for resectable pancre-atic cancer （口頭発表） 2024/02/22 23. The clinical validity of droplet digital PCR to identify KRAS mutations using blood or cytology specimens in pancreatic cancer （口頭発表） 2024/02 24. Comprehensive clinico-molecular profile and efficacy of anti-HER2 therapy for HER2-amplified biliary tract cancer （ポスター） 2024/01 25. Prognostic effects of co-occurring TP53 and KRAS aberrations in patients with advanced biliary tract cancer. （ポスター） 2024/01 26. Safety and efficacy of chemotherapy for patients (pts) with unresectable pancreatic cancer (uPC) concomitant with collagen disease: A multicenter retrospective observational study （ポスター） 2024/01 27. Durable efficacy of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) non-small cell lung cancer (NSCLC) （口頭発表） 2023/12/01 28. センターの設置による胆道・膵臓病に対する多科および多職種連携 （ポスター，一般） 2023/11/04 29. 切除不能または再発胆道癌患者に対する二次以降の薬物療法としてのFOLFOX療法の有効性及び安全性の検討（JON-2107B） （口頭発表） 2023/09 30. 切除可能膵頭部に対するNAC-GSについての現況と課題 （口頭発表，一般） 2023/07/21 31. A study to evaluate the clinical utility of stress data collection in cancer patients treated with chemotherapy （ポスター） 2023/03/17 32. がん薬物療法患者におけるストレスデータ収集の有用性に関する研究 （ポスター） 2023/03/17 33. 切除不能進行大腸癌におけるCDC37遺伝子発現のレゴラフェニブ療法の効果予測 （口頭発表） 2023/03/16 34. 胃癌患者における免疫関連有害事象の予測因子としての自己免疫疾患関連抗体の臨床的意義 （口頭発表） 2023/02/25 35. Treatment for elderly gastric cancer patients-Geriatric assessment and clinical outcomes- （口頭発表） 2023/02/24 36. 切除可能膵頭部癌に対するNAC-GSについての現況と課題 （口頭発表，一般） 2023/02/17 37. 胃癌ゲノムプロファイリングによるdruggable alterationの同定 （口頭発表） 2023/02 38. 高齢胃癌患者における高齢者機能評価と臨床経過 （口頭発表） 2023/02 39. Outcomes of FOLFIRINOX and gemcitabine plus nab-paclitaxel in patients with early recurrent pancreatic cancer after adjuvant S-1: A propensity score–matching analysis.  2023/01/20 40. Interim analysis results of gut microbiota in patients with unresectable cholangiopancreatic cancer: SCRUM-Japan MONSTAR-SCREEN.  2023/01/19 41. リアルワールドデータ（RWD）から見た小腸癌のゲノムランドスケープ （口頭発表） 2022/10 42. 食道扁平上皮癌・胃食道接合部癌におけるctDNAを用いた治療戦略 （口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2022/09/25 43. 切除可能大腸がん高齢患者の高齢者機能評価と臨床経過 （ポスター） 2022/06/18 44. Predictive value of CDC37 gene expression for targeted therapy in metastatic colorectal cancer (mCRC). （ポスター） 2022/06/04 45. Efficacy and safety of zenocutuzumab, a HER2 x HER3 bispecific antibody, in advanced NRG1 fusion-positive (NRG1+) cancer  2022/06/03 46. Identification of an optimal circulating tumor DNA (ctDNA) shedding threshold to detect actionable driver mutations in colorectal and pancreatic adenocarcinoma.  2022/06/03 47. 遠隔医療を用いた治験プレスクリーニング検査の実装  2022/02/17 48. Somatostatin receptor: a potential new therapeutic target for primary mucinous neoplasm of the appendix. （口頭発表） 2022/02 49. Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing.  2022/01/20 50. Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions  2021/11/26 51. Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions  2021/09/23 52. 進行膵癌におけるリキッドバイオプシーと、KRAS野生型膵癌の治療開発に関する取り組み  2021/09/22 53. Genomic landscape in advanced gastric cancer from real-world data (RWD) of clinical genomic testing （ポスター，一般） 2021/09/21 54. Efficacy and safety of zenocutuzumab in advanced pancreatic cancer and other solid tumors harboring NRG1 fusions  2021/06/04 55. Genomic alterations for novel targeted therapies in pancreatobiliary cancers from real-world data （ポスター，一般） 2021/06/04 56. 進行固形がん患者における免疫チェックポイント阻害薬導入前の抗体検査と免疫関連有害事象との関連性  2021/02/19 57. A translational study to evaluate genomic markers and concordance with circulating-tumor DNA and circulating tumor cells to predict clinical outcomes in gastrointestinal and pancreatobiliary cancers: Valor trial. （ポスター） 2021/01/15 58. Efficacy of chemotherapy for patients with unresectable or recurrent pancreatic adenosquamous carcinoma: A multicenter retrospective analysis.  2021/01/15 59. Multi-gene panel testing in patients with gastro-intestinal cancers: A retrospective study. （口頭発表，一般） 2020/10/23 60. 高齢者胃癌に対する治療の工夫 （口頭発表，シンポジウム・ワークショップ・パネルディスカッション等） 2020/10/22 61. 血管新生阻害薬による化学療法中に下腸間膜動静脈瘻を合併した大腸癌症例 （ポスター，一般） 2020/08/11 62. Association of gastric acid suppression with efficacy of immune checkpoint inhibitors （口頭発表） 2019/07/20 5件表示 全件表示(62件)